Showing results (71-80 of 170) with videos related to
Sort By:
Pageof 17
Frontiers in Immunology|October 2, 2023
T cell memory revisited using single telomere length analysisLaureline Roger, Kelly L Miners, Louise Leonard, et al.Pharmacoeconomics|December 6, 2011
Dronedarone for the treatment of atrial fibrillation: a NICE single technology appraisalClaire McKenna, Emma Maund, Muhammad Sarowar, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2005
Common polymorphism G(-248)A in the promoter region of the bax gene results in significantly shorter survival in patients with chronic lymphocytic Leukemia once treatment is initiatedJane Starczynski, Chris Pepper, Guy Pratt, et al.Pharmacoeconomics|April 27, 2013
Dabigatran for the prevention of stroke and systemic embolism in atrial fibrillation: A NICE single technology appraisalRita Faria, Eldon Spackman, Jane Burch, et al.Blood|March 19, 2014
Development and characterization of a physiologically relevant model of lymphocyte migration in chronic lymphocytic leukemiaElisabeth Walsby, Andrea Buggins, Stephen Devereux, et al.European Journal of Haematology|November 15, 2002
Retinoid-induced apoptosis in B-cell chronic lymphocytic leukaemia cells is mediated through caspase-3 activation and is independent of p53, the retinoic acid receptor, and differentiationChris Pepper, Khalida Ali, Alun Thomas, et al.Leukemia Research|February 7, 2006
Two germ line polymorphisms of the tumour suppressor gene p53 may influence the biology of chronic lymphocytic leukaemiaGeothy Kochethu, Julio Delgado, Chris Pepper, et al.British Journal of Haematology|November 28, 2008
Nuclear factor-kappaB as a potential therapeutic target for the novel cytotoxic agent LC-1 in acute myeloid leukaemiaChristopher Jenkins, Saman Hewamana, Amanda Gilkes, et al.RSC Medicinal Chemistry|May 30, 2025
Design, synthesis and evaluation of pyrrolobenzodiazepine (PBD)-based PROTAC conjugates for the selective degradation of the NF-κB RelA/p65 subunitPeiqin Jin, Md Mahbub Hasan, Andrea G S Pepper, et al.Oncotarget|November 10, 2018
PARP1 is required for preserving telomeric integrity but is dispensable for A-NHEJAdam Harvey, Nicholas Mielke, Julia W Grimstead, et al.Pageof 17